74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
McKesson Corp
Closed
SectorHealthcare
774.42 -2.15
Overview
Share price change
24h
Min
773.48
Max
792
Income | -522M 784M |
|---|---|
Sales | 7B 98B |
P/E Sector Avg | 30.767 36.442 |
Dividend yield | 0.37 |
Profit margin | 0.801 |
Employees | 43,000 |
EBITDA | -454M 1.3B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +5.38% upside |
Dividend yield Sector Avg | 0.37% 3.00% |
|---|---|
Next Earnings | 5 Nov 2025 |
Next Ex Dividend date | 1 Dec 2025 |
Market Cap | 6.9B 96B |
|---|---|
Previous open | 776.57 |
Previous close | 774.42 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
McKesson Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
McKesson Corp Forecast
Price Target
By TipRanks
5.38% upside
12 Months Forecast
Average 834.54 USD 5.38%
High 900 USD
Low 763 USD
Based on 14 Wall Street analysts offering 12 month price targets forMcKesson Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About McKesson Corp
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Live chat